In the USA, the prevalence has nearly doubled; with 9.6% of all children between the ages 2 and 19 years and 38% of children with obesity estimated to have fatty liver disease (defined by being overweight with a body-mass index (BMI) > 95th percentile with high ALT concentrations) [6]. The gene discussed is GPT; the disease is fatty liver disease.